This Is Too Hot For Protagonist Therapeutics Inc (NASDAQ: PTGX), Let’s Take A Closer Look

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NASDAQ listed company, PTGX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Protagonist Therapeutics Inc is $2.33B. A total of 0.64 million shares were traded on the day, compared to an average of 685.66K shares.

In the most recent transaction, MOLINA ARTURO MD sold 26,000 shares of PTGX for 44.70 per share on Nov 27 ’24. After the transaction, the Chief Medical Officer now owns 46,444 company shares. In a previous transaction on Nov 26 ’24, MOLINA ARTURO MD sold 5,529 shares at 45.60 per share. PTGX shares that Chief Medical Officer owns now total 46,444.

Among the insiders who sold shares, Gupta Suneel disposed of 103,437 shares on Nov 25 ’24 at a per-share price of $46.04. This resulted in the Chief Development Officer holding 256,174 shares of PTGX after the transaction. In another insider transaction, Gupta Suneel sold 19,191 shares at $45.50 per share on Nov 26 ’24. Company shares held by the Chief Development Officer now total 266,983.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, PTGX has a high of $48.89 and a low of $20.36.

As of this writing, PTGX has an earnings estimate of $1.03 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $1.26 per share and a lower estimate of $1.03.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. PTGX’s latest balance sheet shows that the firm has $326.90M in Cash & Short Term Investments as of fiscal 2021. There were $5.86M in debt and $44.02M in liabilities at the time. Its Book Value Per Share was $8.94, while its Total Shareholder’s Equity was $300.02M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTGX is Buy with a score of 4.80.

Most Popular

Related Posts